Byetta is a class of drugs known as GLP-1 analog, which is one approach among many to the problem of getting the body of a diabetic to produce enough of its own insulin (and suppressing its tendency to produce too much sugar).

FORBES: Diabetes Market Booms As Substitutes Sought For Daily Insulin Dosing

But their real problem was with their heads, the one part of their body that got hit over and over again.

NEWYORKER: Offensive Play